Document is current
Any future updates will be listed below
-
Authors
Senner, Fanny
Hiendl, Lena
Bengesser, Susanne
Adorjan, Kristina
Anghelescu, Ion-George
Baune, Bernhardt T.
Budde, Monika https://orcid.org/0000-0001-7301-9157
Dannlowski, Udo https://orcid.org/0000-0002-0623-3759
Dietrich, Detlef E.
Falkai, Peter
Fallgatter, Andreas J.
Hasan, Alkomiet
Heilbronner, Maria
Jäger, Markus
Juckel, Georg
Kalman, Janos L. https://orcid.org/0000-0003-0930-4214
Konrad, Carsten https://orcid.org/0000-0001-7015-3860
Kohshour, Mojtaba Oraki https://orcid.org/0000-0002-1357-2636
Papiol, Sergi https://orcid.org/0000-0001-9366-8728
Reich-Erkelenz, Daniela
Reimer, Jens
Schaupp, Sabrina K.
Schmauß, Max
Senner, Simon
Spitzer, Carsten
Vogl, Thomas
Zimmermann, Jörg
Heilbronner, Urs https://orcid.org/0000-0001-7135-762X
Schulte, Eva C. https://orcid.org/0000-0003-3105-5672
Schulze, Thomas G.
Reininghaus, Eva Z. https://orcid.org/0000-0001-5964-4087
Kirchner, Sophie-Kathrin
Dalkner, Nina
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SCHU 1603/4-1, 5-1, 7-1; FA241/16-1, SCHU 1603/4-1, 5-1, 7-1; FA241/16-1)
2016 NARSAD Young Investigator Grant
European Union’s Horizon 2020 Research Innovation Programme
Munich Clinician Scientist Program
Dr. Lisa Oehler Foundation
- License Information
-
More Information
Article History
Received: 24 August 2022
Revised: 8 February 2023
Accepted: 16 February 2023
First Online: 25 March 2023
Competing interests
: PF was an honorary speaker for AstraZeneca, Bristol Myers Squibb, Lilly, Essex, GE Healthcare, GlaxoSmithKline, Janssen Cilag, Lundbeck, Otsuka, Pfizer, Servier, and Takeda and a member of the advisory boards of Janssen-Cilag, AstraZeneca, Lilly, Lundbeck, Richter, Recordati, and Boehringer Ingelheim. CK received fees for an educational program from Aristo Pharma, Janssen-Cilag, Lilly, MagVenture, Servier, and Trommsdorff and travel support and speakers honoraria from Aristo Pharma, Janssen-Cilag, Lundbeck, Neuraxpharm, and Servier. AH received paid speakerships from Janssen, Otsuka, Recordati and Lundbeck and was member of Recordati, Rovi, Otsuka, Lundbeck, and Janssen advisory boards. JZ was member of Biogen Advisory Board. All other authors report no competing interests.
